0000899243-16-034863.txt : 20161202 0000899243-16-034863.hdr.sgml : 20161202 20161202180029 ACCESSION NUMBER: 0000899243-16-034863 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20161201 FILED AS OF DATE: 20161202 DATE AS OF CHANGE: 20161202 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIODELIVERY SCIENCES INTERNATIONAL INC CENTRAL INDEX KEY: 0001103021 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 352089858 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4131 PARKLAKE AVENUE STREET 2: SUITE 225 CITY: RALEIGH STATE: NC ZIP: 27612 BUSINESS PHONE: 919 582 9050 MAIL ADDRESS: STREET 1: 4131 PARKLAKE AVENUE STREET 2: SUITE 225 CITY: RALEIGH STATE: NC ZIP: 27612 FORMER COMPANY: FORMER CONFORMED NAME: MAS ACQUISITION XXIII CORP DATE OF NAME CHANGE: 20000111 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SEARS SAMUEL P JR CENTRAL INDEX KEY: 0001238483 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31361 FILM NUMBER: 162032288 BUSINESS ADDRESS: STREET 1: 1 FIELDSTONE DRIVE CITY: WINCHESTER STATE: MA ZIP: 01890 BUSINESS PHONE: 5083857367 MAIL ADDRESS: STREET 1: 1 FIELDSTONE DRIVE CITY: WINCHESTER STATE: MA ZIP: 01890 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-12-01 0 0001103021 BIODELIVERY SCIENCES INTERNATIONAL INC BDSI 0001238483 SEARS SAMUEL P JR C/O BIODELIVERY SCIENCES INTL, INC., 4131 PARKLAKE AVENUE, SUITE 225 RALEIGH NC 27612 1 0 0 0 Common Stock 2016-12-01 4 S 0 12000 1.67 D 64863 D The shares of Issuer's Common Stock were sold pursuant to a pre-planned 10b5-1 plan to cover the Reporting Person's tax liability upon the vesting of RSUs in August 2016. On December 1, 2016, the Reporting Person sold an aggregate of 12,000 shares of the Issuer's Common Stock at a weighted average price of $1.67 per share. The highest sale price for the Common Stock was $1.75 per share and the lowest sale price was $1.60 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The Form 4 filed on August 12, 2016 inadvertently excluded 1,000 shares held by the Reporting Person. /s/ Samuel P. Sears Jr. 2016-12-02